Rachna Khosla is a Vice President in Business Development at Amgen. She leads a team that is responsible for corporate development, strategic collaborations, M&A and licensing/out-licensing activities. In 2019 her team led the BeiGene collaboration and both the Otezla and Nuevolution acquisitions. Rachna joined Amgen in 2013. Rachna brings over 26 years of experience in strategic biotech and pharma deal-making. Previously, Rachna held leadership positions as a healthcare M&A banker at Lazard Freres & Co., Credit Suisse, JPMorgan and Salomon Brothers. Rachna also spent 2.5 years at Aventis Capital, Aventis’ corporate venture capital arm, where she was a member of the investment committee and managed a portfolio of assets worth over a $1B. She has been involved with announced deals over $165B in total value. Rachna serves as a member on the Advisory Council for the Alliance for SoCal Innovation and as a member of the Healthcare Sector Advisory Board for the Partnership Fund for New York City. Rachna received her MBA from Columbia Business School and her BA from Barnard College, Columbia University. She attended the London School of Economics for one year while at Barnard.